Black cohosh (Cimicifuga racemosa) in tamoxifen-treated breast cancer patients with climacteric complaints – a prospective observational study

References

• Holmberg L, Anderson H. HABITS (hormonal replacement therapy after breast cancer – is it safe?), a randomised comparison: trial stopped. Lancet 2004;363:453–455.
   PubMed Web of Science ®Google Scholar
• Newton KM, Reed SD, LaCroix AZ, Grothaus LC, Ehrlich K, Guiltinan J. Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo: a randomized trial. Ann Intern Med 2006;145:869–879.
   PubMed Web of Science ®Google Scholar
• Wong VC, Lim CE, Luo X, Wong WS. Current alternative and complementary therapies used in menopause. Gynecol Endocrinol 2009;25:166–174.
   PubMed Web of Science ®Google Scholar
• Rotem C, Kaplan B. Phyto-Female Complex for the relief of hot flushes, night sweats and quality of sleep: randomized, controlled, double-blind pilot study. Gynecol Endocrinol 2007;23:117–122.
   PubMed Web of Science ®Google Scholar
• Julia Molla MD, Garcia-Sanchez Y, Romeu Sarri A, Perez-lopez FR. Cimicifuga racemosa treatment and health related quality of life in post-menopausal Spanish women. Gynecol Endocrinol 2009;25:21–26.
   PubMed Web of Science ®Google Scholar
• Bai W, Henneicke-von Zepelin HH, Wang S, Zheng S, Liu J, Zhang Z, Geng L, Hu Jiao C, Liske E. Efficacy and tolerability of a medicinal product containing an isopropanolic black cohosh extract in Chinese women with menopausal symptoms: a randomized, double blind, parallel-controlled study versus tibolone. Maturitas 2007;58:31–41.
   PubMed Web of Science ®Google Scholar
• Oktem M, Eroglu D, Karahan HB, Taskintuna N, Kuscu E, Zeyneloglu HB. Black cohosh and fluoxetine in the treatment of postmenopausal symptoms: a prospective, randomized trial. Adv Ther 2007;24:448–461.
   PubMed Web of Science ®Google Scholar
• Nappi RE, Malavasi B, Brundu B, Facchinetti F. Efficacy of Cimicifuga racemosa on climacteric complaints: a randomized study versus low-dose transdermal estradiol. Gynecol Endocrinol 2005;20:30–35.
   PubMed Web of Science ®Google Scholar
• Palacio C, Masri G, Mooradian AD. Black cohosh for the management of menopausal symptoms : a systematic review of clinical trials. Drugs Aging 2009;26:23–36.
   Google Scholar
• Sammartino A, Tommaselli GA, Gargano V, di Carlo C, Attianese W, Nappi C. Short-term effects of a combination of isoflavones, lignans and Cimicifuga racemosa on &#132>;climacteric-related symptoms in postmenopausal women: a double-blind, randomized, placebo-controlled trial. Gynecol Endocrinol 2006;22:646–650.
   PubMed Web of Science ®Google Scholar
• Reame NE, Lukacs JL, Padmanabhan V, Eyvazzadeh AD, Smith YR, Zubieta JK. Black cohosh has central opioid activity in postmenopausal women: evidence from naloxone blockade and positron emission tomography neuroimaging. Menopause 2008;15:832–840.
   PubMed Web of Science ®Google Scholar
• Jarry H, Metten M, Spengler B, Christoffel V, Wuttke W. In vitro effects of the Cimicifuga racemosa extract BNO 1055. Maturitas 2003;44 (Suppl 1):S31–S38.
   PubMed Web of Science ®Google Scholar
• Walji R, Boon H, Guns E, Oneschuk D, Younus J. Black cohosh (Cimicifuga racemosa [L.] Nutt.): safety and efficacy for cancer patients. Support Care Cancer 2007;15:913–921.
   PubMed Web of Science ®Google Scholar
• Borrelli F, Ernst E. Black cohosh (Cimicifuga racemosa): a systematic review of adverse events. Am J Obstet Gynecol 2008;199:455–466.
   PubMed Web of Science ®Google Scholar
• Bodinet C, Freudenstein J. Influence of Cimicifuga racemosa on the proliferation of estrogen receptor-positive human breast cancer cells. Breast Cancer Res Treat 2002;76:1–10.
   PubMed Web of Science ®Google Scholar
• Freudenstein J, Dasenbrock C, Nisslein T. Lack of promotion of estrogen-dependent mammary gland tumors in vivo by an isopropanolic Cimicifuga racemosa extract. Cancer Res 2002;62:3448–3452.
   PubMed Web of Science ®Google Scholar
• Jacobson JS, Troxel AB, Evans J, Klaus L, Vahdat L, Kinne D, Lo KM, Moore A, Rosenman PJ, Kaufman EL, Neugut AI, Grann VR. Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer. J Clin Oncol 2001;19:2739–2745.
   PubMed Web of Science ®Google Scholar
• Hernandez Munoz G, Pluchino S. Cimicifuga racemosa for the treatment of hot flushes in women surviving breast cancer. Maturitas 2003;44 (Suppl 1): S59–S65.
   PubMedGoogle Scholar
• Pockaj BA, Gallagher JG, Loprinzi CL, Stella PJ, Barton DL, Sloan JA, Lavasseur BI, Rao RM, Fitch TR, Rowland KM, Novotny PJ, Flynn PJ, Richelson E, Fauq AH. Phase III double-blind, randomized, placebo-controlled crossover trial of black cohosh in the management of hot flashes: NCCTG Trial N01CC1. J Clin Oncol 2006;24:2836–2841.
   PubMed Web of Science ®Google Scholar
• Pockaj BA, Loprinzi CL, Sloan JA, Novotny PJ, Barton DL, Hagenmaier A, Zhang H, Lambert GH, Reeser KA, Wisbey JA. Pilot evaluation of black cohosh for the treatment of hot flashes in women. Cancer Invest 2004;22:515–521.
   PubMed Web of Science ®Google Scholar
• Sickmueller B, Mueller J. Observational studies – the German experience. Regul Aff J 2004;12:247–250.
   Google Scholar
• Potthoff P, Heinemann L, Schneider HP. Menopause-Rating-Skala (MRS II): methodische standardisierung in der deutschen bevölkerung. Zentralbl Gynakol 2000;122: 280–286.
   PubMedGoogle Scholar
• Schneider HPG, Behr HM. Contemporary evaluation of climacteric complaints: its impact on quality of life. Hormone replacement therapy and quality of life. In: Heinemann LAJ, Potthoff P, Schneider HPG, editors. New York: The Parthenon Publishing Group; 2003:45–61.
   Google Scholar
• Hauser GA, Ernst U. [Evaluation of hormone replacement therapy in the perimenopause by means of Menopause Rating Scale (MRS I)]. Zentralbl Gynakol 1999;121:530–536.
   Google Scholar
• Briese V, Stammwitz U, Friede M. Wechseljahrestherapie ohne Hormone – Ergebnisse einer aktuellen Anwendungsbeobachtung. J Menopause 2005;12:11–12.
   Google Scholar
• Osmers R, Friede M, Liske E, Schnitker J, Freudenstein J, Henneicke-von Zepelin HH. Efficacy and safety of isopropanolic black cohosh extract for climacteric symptoms. Obstet Gynecol 2005;105:1074–1083.
   PubMed Web of Science ®Google Scholar
• Liske E, Hanggi W, Henneicke-von Zepelin HH, Boblitz N, Wustenberg P, Rahlfs VW. Physiological investigation of a unique extract of black cohosh (Cimicifugae racemosae rhizoma): a 6-month clinical study demonstrates no systemic estrogenic effect. J Womens Health Gend Based Med 2002;11:163–174.
   PubMedGoogle Scholar
• Partridge AH, Wang PS, Winer EP, Avorn J. Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. J Clin Oncol 2003;21:602–606.
   PubMed Web of Science ®Google Scholar
• Grunfeld EA, Hunter MS, Sikka P, Mittal S. Adherence beliefs among breast cancer patients taking tamoxifen. Patient Educ Couns 2005;59:97–102.
   PubMed Web of Science ®Google Scholar
• Ziller V, Kalder M, Albert US, Holzhauer W, Ziller M, Wagner U, Hadji P. Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer. Ann Oncol 2009;20:431–436.
   PubMed Web of Science ®Google Scholar